Increased levels of plasma ANP, which were associated with aging, preceded the development of CKD in local residents without overt cardiovascular diseases, suggesting a possible role of this bioactive peptide in the development of CKD in the general population of Japan. This evidence concerns the gene NPPA and chronic kidney disease.